BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling
Shuai Wu(Peking University), Hsiang‐Ying Lee(Kaohsiung Medical University)
Cited by 6
Related Papers
Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors
|Science Translational Medicine|2017|106
Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
|Oncotarget|2017|38
c-MYC responds to glucose deprivation in a cell-type-dependent manner
|Cell Death Discovery|2015|22